vimarsana.com

Page 19 - Managing Science Editor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Proposed Anti-inflammatory MS Treatment Found Non-toxic in Zebrafish

TnP is a peptide, or short protein fragment, from the venomous toadfish Thalassophreyne nattereri, found along Brazil’s northern and northeastern coasts. It has shown anti-inflammatory and anti-allergic effects, as well as preliminary effectiveness in treating MS and asthma in mouse models of those conditions. Researchers at the Butantan Institute Special Laboratory for Applied Toxicology, in São Paulo, Brazil, recently found that TnP can delay the onset of more severe MS symptoms in mice and lessen their impact. But the toxicity of this compound has yet to be addressed in animal studies. The zebrafish, a common laboratory animal used in early drug development, is deemed a good candidate to test toxicity as an alternative to rodents and other mammals. It shares about 70% of its genome with humans and has conserved metabolism and physiology.

Emerald Health Preparing for Phase 2 Trial of EHP-101 for Relapsing MS

Emerald Health Preparing for Phase 2 Trial of EHP-101 for Relapsing MS 4.3 (12) Emerald Health Pharmaceuticals (EHP) is preparing for an international Phase 2 clinical trial testing EHP-101 for the treatment of multiple sclerosis (MS). The study will take place in about 20 locations in the U.S. and Australia, and is expected to include approximately 50 patients with relapsing forms of MS  relapsing-remitting and relapsing secondary progressive MS. Enrollment is expected to begin later this year. “The initiation of this MS Phase 2 study is another important milestone for our lead product candidate, EHP-101,” Joachim Schupp, MD, EHP’s chief medical officer, said in a press release.

Novartis, iHeartRadio Team Up for A Night for MS Awareness on March 11

Novartis, iHeartRadio Team Up for A Night for MS Awareness on March 11
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.